Publication: 3151

Publication: 3151

Alliance A041701 - A randomized phase 2/3 study of conventional chemotherapy +/- uproleselan (GMI-1271) in older adults with acute myeloid leukemia receiving intensive induction chemotherapy

DOI

URL

Google Scholar

Citation:: Blood vol 134 (Supplement 1) abstract 1366

Meeting Instance:: ASH 2019
Year:: 2019
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:: Older Adult

Pharmas:
Grants:: U10CA180821, U10CA180882, UG1CA189823, U24CA196171; U10CA180820 (ECOG-ACRIN); U10CA180888, UG1CA233270 (SWOG)

Corr. Author:
Authors:: Geoffrey L. Uy Vivien Yin Heidi Klepin Shira Dinner Anthony Jaslowski Steven A. Strickland Jane L. Liesveld John C. Byrd Richard M. Stone

Networks:: LAPS-IL036, LAPS-MA036, LAPS-MO011, LAPS-TN008, NC002, OH070, WINCORP

Study: Alliance-A041701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2/3

Keywords: